Terms: = Prostate cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
620 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
3. Androgen receptor cofactors: A potential role in understanding prostate cancer.
Li X; Xiong H; Mou X; Huang C; Thomas ER; Yu W; Jiang Y; Chen Y
Biomed Pharmacother; 2024 Apr; 173():116338. PubMed ID: 38417290
[TBL] [Abstract] [Full Text] [Related]
4. Stromal-derived MAOB promotes prostate cancer growth and progression.
Pu T; Wang J; Wei J; Zeng A; Zhang J; Chen J; Yin L; Li J; Lin TP; Melamed J; Corey E; Gao AC; Wu BJ
Sci Adv; 2024 Feb; 10(6):eadi4935. PubMed ID: 38335292
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
Pimenta R; Malulf FC; Romão P; Caetano GVB; da Silva KS; Ghazarian V; Dos Santos GA; Guimarães V; Silva IA; de Camargo JA; Recuero S; Melão BVLA; Antunes AA; Srougi M; Nahas W; Leite KRM; Reis ST
J Cancer Res Clin Oncol; 2024 Feb; 150(2):70. PubMed ID: 38305916
[TBL] [Abstract] [Full Text] [Related]
6. Antitumor Activity and Mechanism of Terpenoids in Seaweeds Based on Literature Review and Network Pharmacology.
Chen B; Li Y; Li W; Ye S; Zhu L; Ding Y
Adv Biol (Weinh); 2024 Mar; 8(3):e2300541. PubMed ID: 38134388
[TBL] [Abstract] [Full Text] [Related]
7. Androgen Receptor-Interacting Proteins in prostate cancer Development and Therapy Resistance.
Culig Z; Puhr M
Am J Pathol; 2024 Mar; 194(3):324-334. PubMed ID: 38104650
[TBL] [Abstract] [Full Text] [Related]
8. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells.
Dai X; Shi X; Luo M; Li P; Gao Y
BMC Cancer; 2023 Dec; 23(1):1241. PubMed ID: 38104097
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
[TBL] [Abstract] [Full Text] [Related]
10. A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer.
Wang CW; Clémot M; Hashimoto T; Diaz JA; Goins LM; Goldstein AS; Nagaraj R; Banerjee U
Sci Signal; 2023 Nov; 16(810):eabo5213. PubMed ID: 37934809
[TBL] [Abstract] [Full Text] [Related]
11. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller KA; Degan S; Wang Y; Cohen J; Ku SY; Goodrich DW; Gelman IH
Oncogene; 2024 Jan; 43(1):22-34. PubMed ID: 37875657
[TBL] [Abstract] [Full Text] [Related]
12. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
13. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
[TBL] [Abstract] [Full Text] [Related]
14. Bioassay-Guided Fractionation and Biological Activity of Cardenolides from Streptocaulon juventas.
Xu Y; Xu J; Zhu W; Yan Y; Jiang X; Xie Z; Feng F; Zhang J
Planta Med; 2023 Dec; 89(15):1444-1456. PubMed ID: 37709286
[TBL] [Abstract] [Full Text] [Related]
15. PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate.
Chessa TAM; Jung P; Anwar A; Suire S; Anderson KE; Barneda D; Kielkowska A; Sadiq BA; Lai IW; Felisbino S; Turnham DJ; Pearson HB; Phillips WA; Sasaki J; Sasaki T; Oxley D; Spensberger D; Segonds-Pichon A; Wilson M; Walker S; Okkenhaug H; Cosulich S; Hawkins PT; Stephens LR
Mol Cell; 2023 Aug; 83(16):2991-3009.e13. PubMed ID: 37567175
[TBL] [Abstract] [Full Text] [Related]
16. Appearance of tuft cells during prostate cancer progression.
Vlajic K; Pennington Kluger H; Bie W; Merrill BJ; Nonn L; Kajdacsy-Balla A; Tyner AL
Oncogene; 2023 Jul; 42(31):2374-2385. PubMed ID: 37386128
[TBL] [Abstract] [Full Text] [Related]
17. A Triazaspirane Derivative Inhibits Migration and Invasion in PC3 prostate cancer Cells.
Vasconcelos-Ulloa JJ; García-González V; Valdez-Salas B; Vázquez-Jiménez JG; Rivero-Espejel I; Díaz-Molina R; Galindo-Hernández O
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299000
[TBL] [Abstract] [Full Text] [Related]
18. Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced prostate cancer.
Pimenta R; Mioshi CM; Gonçalves GL; Candido P; Camargo JA; Guimarães VR; Chiovatto C; Ghazarian V; Romão P; da Silva KS; Dos Santos GA; Silva IA; Srougi M; Nahas WC; Leite KR; Viana NI; Reis ST
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298588
[TBL] [Abstract] [Full Text] [Related]
19. NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness.
Folcher A; Gordienko D; Iamshanova O; Bokhobza A; Shapovalov G; Kannancheri-Puthooru D; Mariot P; Allart L; Desruelles E; Spriet C; Diez R; Oullier T; Marionneau-Lambot S; Brisson L; Geraci S; Impheng H; Lehen'kyi V; Haustrate A; Mihalache A; Gosset P; Chadet S; Retif S; Laube M; Sobilo J; Lerondel S; Villari G; Serini G; Pla AF; Roger S; Fromont-Hankard G; Djamgoz M; Clezardin P; Monteil A; Prevarskaya N
EMBO J; 2023 Jul; 42(13):e112198. PubMed ID: 37278161
[TBL] [Abstract] [Full Text] [Related]
20. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water.
Zhang GH; Liu H; Liu MH; Liu YC; Wang JQ; Wang Y; Wang X; Xiang Z; Liu W
Comb Chem High Throughput Screen; 2024; 27(1):101-117. PubMed ID: 37170985
[TBL] [Abstract] [Full Text] [Related]
[Next]
